Benzinga | Jul 19, 2021 05:19AM EDT

JP Morgan Initiates Coverage On Monte Rosa Therapeutics with Overweight Rating, Announces Price Target of $38

JP Morgan analyst Eric Joseph initiates coverage on Monte Rosa Therapeutics (NASDAQ:GLUE) with a Overweight rating and announces Price Target of $38.